Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ARCUTIS BIOTHERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 231,734 shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $6.7M as of 2025-Q4. The position was decreased (-5.0% shares). ARQT represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$6.7M
Current Shares
231,734
Total Value Change
+$4.2M
Total Shares Change
-42,045
Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC
Decreased |
| 231,734 |
-5.0% |
| $6.7M |
| 0.0% |
| $28.08 |
0 |
| 2025-Q3 | Decreased | 244,015 | -39.7% | $4.6M | 0.0% | $18.62 | 0 |
| 2025-Q2 | Increased | 404,736 | +45.0% | $5.7M | 0.0% | $13.74 | 37 |
| 2025-Q1 | Decreased | 279,047 | -0.4% | $4.4M | 0.0% | $15.73 | 0 |
| 2024-Q4 | Increased | 280,100 | +1.2% | $3.9M | 0.0% | $14.20 | 27 |
| 2024-Q3 | Increased | 276,691 | +1.1% | $2.6M | 0.0% | $9.36 | 26 |
| 2024-Q2 | New | 273,779 | - | $2.5M | 0.0% | $9.30 | 36 |